In total, in our patient population with OI, we detected 27 mutations in the COL1A1/COL1A2 genes; 10 of them were not previously described in the literature, which is 37% (10/27) of all identified mutations in these two genes. This evidence concerns the gene COL1A2 and osteogenesis imperfecta.